These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 28025702)

  • 1. Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study.
    Kiso M; Yoshihara M; Ito M; Inoue K; Kato K; Nakajima S; Mabe K; Kobayashi M; Uemura N; Yada T; Oka M; Kawai T; Boda T; Kotachi T; Masuda K; Tanaka S; Chayama K
    Gastric Cancer; 2017 Sep; 20(5):764-771. PubMed ID: 28025702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
    Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
    Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm.
    Choi HS; Lee SY; Kim JH; Sung IK; Park HS; Shim CS; Jin CJ
    J Dig Dis; 2014 Jun; 15(6):293-8. PubMed ID: 24602176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological Evaluation of Gastric Cancer Risk Based on Pepsinogen and Helicobacter pylori Antibody: Relationship to Endoscopic Findings.
    Kotachi T; Ito M; Yoshihara M; Boda T; Kiso M; Masuda K; Matsuo T; Tanaka S; Chayama K
    Digestion; 2017; 95(4):314-318. PubMed ID: 28571035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
    Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
    Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
    Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
    Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels.
    Yanaoka K; Oka M; Ohata H; Yoshimura N; Deguchi H; Mukoubayashi C; Enomoto S; Inoue I; Iguchi M; Maekita T; Ueda K; Utsunomiya H; Tamai H; Fujishiro M; Iwane M; Takeshita T; Mohara O; Ichinose M
    Int J Cancer; 2009 Dec; 125(11):2697-703. PubMed ID: 19610064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis.
    Watanabe M; Kato J; Inoue I; Yoshimura N; Yoshida T; Mukoubayashi C; Deguchi H; Enomoto S; Ueda K; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Tekeshita T; Mohara O; Ushijima T; Ichinose M
    Int J Cancer; 2012 Dec; 131(11):2632-42. PubMed ID: 22383377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between pepsinogen I/II ratio and age or upper gastrointestinal diseases in Helicobacter pylori-positive and -negative subjects].
    Paik CN; Chung IS; Nam KW; Kwon JH; Chang JH; Suh JP; Park JM; Cho YK; Lee IS; Kim SW; Choi MG
    Korean J Gastroenterol; 2007 Aug; 50(2):84-91. PubMed ID: 17928751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Negative Anti-
    Inoue M; Sawada N; Goto A; Shimazu T; Yamaji T; Iwasaki M; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):420-426. PubMed ID: 31826914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status.
    Hansen S; Vollset SE; Derakhshan MH; Fyfe V; Melby KK; Aase S; Jellum E; McColl KE
    Gut; 2007 Jul; 56(7):918-25. PubMed ID: 17317788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori (HP) infection alone, but not HP-induced atrophic gastritis, increases the risk of gastric lymphoma: a case-control study in Japan.
    Ishikura N; Usui Y; Ito H; Kasugai Y; Oze I; Kato S; Yatabe Y; Nakamura S; Matsuo K
    Ann Hematol; 2019 Aug; 98(8):1981-1987. PubMed ID: 31177299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of Helicobacter pylori-induced gastritis by serum pepsinogen levels.
    Kitamura Y; Yoshihara M; Ito M; Boda T; Matsuo T; Kotachi T; Tanaka S; Chayama K
    J Gastroenterol Hepatol; 2015 Oct; 30(10):1473-7. PubMed ID: 25974661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiologic findings on serologically defined chronic atrophic gastritis strongly depend on the choice of the cutoff-value.
    Brenner H; Rothenbacher D; Weck MN
    Int J Cancer; 2007 Dec; 121(12):2782-6. PubMed ID: 17691112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia.
    Leja M; Cine E; Rudzite D; Vilkoite I; Huttunen T; Daugule I; Rumba-Rozenfelde I; Pimanov S; Liepniece-Karele I; Pahomova J; Purmalis K; Eglitis J; Pirags V; Dzerve V; Erglis A
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1410-7. PubMed ID: 23114744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
    Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
    Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum pepsinogen and Helicobacter pylori infection--a Japanese population study.
    Toyoda K; Furusyo N; Ihara T; Ikezaki H; Urita Y; Hayashi J
    Eur J Clin Microbiol Infect Dis; 2012 Sep; 31(9):2117-24. PubMed ID: 22354521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Helicobacter pylori and the development of atrophic gastritis].
    Takahashi S; Igarashi H; Masubuchi N; Ishiyama N; Saito S; Aoyagi T; Itoh T; Hirata I
    Nihon Rinsho; 1993 Dec; 51(12):3231-5. PubMed ID: 8283639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
    Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
    Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced method for evaluation of gastric cancer risk by serum markers: determination of true low-risk subjects for gastric neoplasm.
    Boda T; Ito M; Yoshihara M; Kitamura Y; Matsuo T; Oka S; Tanaka S; Chayama K
    Helicobacter; 2014 Feb; 19(1):1-8. PubMed ID: 24215601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.